🇺🇸 FDA
Patent

US 10064933

Recombinant rift valley fever (RVF) viruses and methods of use

granted A61KA61K2039/525A61K2039/5254

Quick answer

US patent 10064933 (Recombinant rift valley fever (RVF) viruses and methods of use) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/525, A61K2039/5254, A61K35/76, A61K39/00